BACKGROUND: Increasing bacterial resistance to antibiotics is one of the most serious problems in current medicine. An important factor contributing to the growing prevalence of multiresistant bacteria is application of antibiotics. This study aimed at analyzing the development of resistance of Enterobacteriaceae to selected beta-lactam, fluoroquinolone and aminoglycoside antibiotics in the University Hospital Olomouc and assessing the effect of selection pressure of these antibiotics. METHODS: For the period between 1 January 2000 and 31 December 2011, resistance of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae and Proteus mirabilis to third- and fourth-generation cephalosporins, meropenem, piperacillin/tazobactam, fluoroquinolones and aminoglycosides was retrospectively studied. For the assessment of selection pressure of antibiotics, a parameter of defined daily dose in absolute annual consumption (DDDatb) based on the ATC/DDD classification and in relative annual consumption (RDDDatb) as the number of defined daily doses per 100 bed-days was used. The relationship between frequency of strains resistant to a particular antibiotic and antibiotic consumption was assessed by linear regression analysis using Spearman's correlation. The level of statistical significance was set at p < 0.05. RESULTS: A total of 113,027 isolates from the Enterobacteriaceae family were analyzed. There was a significant effect of selection pressure of the primary antibiotic in the following cases: piperacillin/tazobactam in Klebsiella pneumoniae, gentamicin in Klebsiella pneumoniae and Escherichia coli and amikacin in Escherichia coli and Enterobacter cloacae. Also, there was significant correlation between resistance to ceftazidime and consumption of piperacillin/tazobactam in Klebsiella pneumoniae and Escherichia coli. No relationship was found between consumption of third- and fourth-generation cephalosporins and resistance to ceftazidime or between fluoroquinolone consumption and resistance to ciprofloxacin. CONCLUSION: The study showed the effects of both direct and indirect selection pressure on increasing resistance to gentamicin, amikacin, piperacillin/tazobactam and ceftazidime. Given the fact that no correlation was found between resistance to fluoroquinolones and consumption of either primary or secondary antibiotics, we assume that the increasing resistance to fluoroquinolones is probably due to circulation of resistance genes in the bacterial population and that this resistance was not affected by reduced use of these antibiotics.

Department of Microbiology Faculty of Medicine and Dentistry Palacký University Olomouc Hněvotínská 3 775 15 Olomouc Czech Republic

Zobrazit více v PubMed

Uvizl R, Hanulik V, Husickova V, Htoutou-Sedlakova M, Adamus M, Kolar M. Hospital-acquired pneumonia in ICU patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155:373–378. PubMed

Pai H, Kang CI, Byeon JH, Lee KD, Park WB, Kim HB, Kim EC, Oh MD, Choe KW. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004;48:3720–3728. PubMed PMC

Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, Citton R, D'Inzeo T, Fadda G, Cauda R, Spanu T. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum beta- lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother. 2007;51:1987–1994. PubMed PMC

Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. Clinical and economic impact of bacteremia with extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2006;50:257–262. PubMed PMC

Kolar M, Latal T, Cermak P, Bartonikova N, Chmelarova E, Sauer P, Kesselova M. Prevalence of extended- -spectrum beta-lactamase-positive Klebsiella pneumoniae isolates in the Czech Republic. Int J Antimicrob Agents. 2006;28:49–53. PubMed

European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. [ http://www.eucast.org/clinical_breakpoints]

Htoutou Sedlakova M, Hanulik V, Chroma M, Hricova K, Kolar M, Latal T, Schaumann R, Rodloff AC. Phenotypic detection of broad-spectrum beta-lactamases in microbiological practice. Med Sci Monit. 2011;17:BR147–BR152. PubMed PMC

Chroma M, Kolar M. Genetic methods for detection of antibiotic resistance: focus on extended-spectrum β-lactamases. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010;154:289–296. PubMed

Anatomical therapeutic chemical (ATC) index (including defined daily doses (DDDs) for plain substances) WHO Collaboration Centre for Drug Statistics Methodology Oslo. 1996.

Bergman U, Christerson I, Jansson B, Wiholm BE. Auditing drug utilization by means of defined daily dose per bed-day. A methodological study. Eur J Clin Pharmacol. 1980;17:183–187. PubMed

Kolar M, Urbanek K, Latal T. Antibiotic selective pressure and development of bacterial resistance. Int J Antimicrob Agents. 2001;17:357–363. PubMed

Urbánek K, Kolář M, Lovečková Y, Strojil J, Šantavá L. Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains. J Clin Pharm Ther. 2007;32:403–408. PubMed

Giamarellou H, Antoniadou A. The effect of monitoring of antibiotic use on decreasing antibiotic resistance in the hospital. Ciba Found Symp. 1997;207:76–86. PubMed

Willemsen I, Bogaers-Hofman D, Winters M, Kluytmans J. Correlation between antibiotic Use and resistance in a hospital: temporary and ward-specific observations. Infection. 2009;37:432–437. PubMed

White AC Jr, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis. 1997;25:230–239. PubMed

Haller P, Tschudin S, Dangel M. Increase of Resistant Enterobacter Isolates and Correlation With Antibiotic Consumption at the Ward Level. 2006. (Poster Presented in 16. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Nice). [ http://www.spitalpharmazie-basel.ch/pdf/ECCMID_Haller.pdf] Accessed April 12, 2012.

Bosso JA, Mauldin PD, Salgado CD. The association between antibiotic use and resistance: the role of secondary antibiotics. Eur J Clin Microbiol Infect Dis. 2010;29:1125–1129. PubMed

Meyer E, Lapatschek M, Bechtold A, Schwarzkopf G, Gastmeier P, Schwab F. Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU. Intensive Care Med. 2009;35:862–870. PubMed

Asensio A, Alvarez-Espejo T, Fernandez-Crehuet J, Ramos A, Vaque-Rafart J, Bishopberger C, Hernandez Navarrete M, Calbo-Torrecillas F, Campayo J, Canton R. Estudio de Prevalencia de las Infecciones Nosocomiales en Espana (EPINE) Working Group. Trends in yearly prevalence of third-generation cephalosporin and fluoroquinolone resistant Enterobacteriaceae infections and antimicrobial use in Spanish hospitals, Spain, 1999 to 2010. Euro Surveill. 2011;16(40):pii=19983. [ http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19983] Accessed April 12, 2012. PubMed

Husickova V, Cekanova L, Chroma M, Htoutou-Sedlakova M, Hricova K, Kolar M. Carriage of ESBL- and AmpC-positive Enterobacteriaceae in the gastrointestinal tract of community subjects and hospitalized patients in the Czech Republic. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012;156:348–353. PubMed

Husickova V, Htoutou-Sedlakova M, Matouskova I, Chroma M, Kolar M. Analysis of enterobacteriaceae producing broad-spectrum beta-lactamases in the intensive care unit setting. Open J Med Microbiol. 2013;3:56–61.

Barbosa TM, Levy SB. The impact of antibiotic use on resistance development and persistence. Drug Resist Updat. 2000;3:303–311. PubMed

Implementation of Antibiotic Stewardship in a University Hospital Setting